Goldman Sachs Starts Allscripts-Misys Healthcare (MDRX) at Neutral

Goldman Sachs initiates coverage on Allscripts-Misys Healthcare (NASDAQ: MDRX) with a Neutral rating and $21 price target.

The firm states, "We believe valuation at current ranges appropriately reflects our riskadjusted growth outlook for the company. However, we remain opportunistic given cross-sell opportunities from recent M&A and the potential for multiple appreciation following improvements in ROIC."

Goldman sees 2011/2012/2013 EPS of $0.91/$1.04/$1.20 versus the consensus of $0.90/$1.06/$1.22.

For more ratings news on Allscripts-Misys Healthcare click here and for the rating history of Allscripts-Misys Healthcare click here.

Shares of Allscripts-Misys Healthcare closed at $18.88 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lake Street Capital Markets Starts Research Solutions Inc. (RSSS) at Buy
• BofA Securities Reinstates Mahanagar Gas Limited (MAHGL:IN) at Buy
• BofA Securities Reinstates Gujarat Gas Ltd (GUJGA:IN) at Underperform